Myeloperoxidase binds to non-vital spermatozoa on phosphatidylserine epitopes

Jacqueline Lessig1, Holger Spalteholz, Uta Reibetanz

  • 1Institute of Medical Physics and Biophysics, Medical Faculty, University of Leipzig, Haertelstr. 16-18, 04107, Leipzig, Germany, juergen.arnhold@medizin.uni-leipzig.de.

Insights

Myeloperoxidase (MPO) binds to apoptotic human spermatozoa, specifically to externalized phosphatidylserine. This suggests MPO plays a role in clearing damaged sperm cells during inflammation.

Area of Science:

  • Reproductive immunology
  • Cellular biology
  • Inflammation research

Background:

  • Polymorphonuclear leukocytes (PMNs) release myeloperoxidase (MPO) during inflammation.
  • Increased PMNs and MPO are found in the genital tracts of patients with inflammation.
  • MPO's interaction with spermatozoa in this context is not well understood.

Purpose of the Study:

  • To investigate the binding of MPO to human spermatozoa.
  • To determine the characteristics of spermatozoa that bind MPO.
  • To elucidate the mechanism and binding sites of MPO-spermatozoa interaction.

Main Methods:

  • Flow cytometry analysis of MPO and annexin V binding to spermatozoa.
  • Assessment of sperm viability using ethidium homodimer I.
  • Competition experiments and gel filtration with liposomes to identify MPO binding sites.

Main Results:

  • MPO binds to a fraction of human spermatozoa, particularly pre-damaged or acrosome-reacted cells.
  • MPO binding correlates with externalized phosphatidylserine (indicating loss of membrane integrity) and ethidium homodimer I incorporation.
  • MPO and annexin V share common binding sites on spermatozoa, and MPO interacts with phosphatidylserine.

Conclusions:

  • Myeloperoxidase interacts with apoptotic human spermatozoa by binding to externalized phosphatidylserine.
  • This interaction suggests a novel role for MPO in the recognition and clearance of apoptotic sperm cells during genital tract inflammation.